Table 1.
STRRIDE I | STRRIDE II | Total | Gene Expression Subset | ||||
---|---|---|---|---|---|---|---|
Failed to Complete Study | Completed Study | Failed to Complete Study | Completed Study | Failed to Complete Study | Completed Study | ||
28 (67) | 72 (172) | 38 (93) | 62 (153) | 33 (160) | 67 (325) | n = 60 | |
Age (y) | 51.3 ± 5.8 | 52.5 ± 4.8 | 46.5 ± 11.8 | 48.8 ± 10.2 | 48.5 ± 10.0 | 50.8 ± 8.6 | 51 ± 1.2 |
Gender**- men | 40 (27) | 55 (94) | 35 (33) | 44 (68) | 37 (60) | 50 (162) | 50 (30) |
Women | 60 (40) | 45 (78) | 65 (60) | 56 (85) | 63 (100) | 50 (163) | 50 (30) |
Race**- white | 58 (39) | 81 (139) | 67 (62) | 86 (131) | 63 (101) | 83 (270) | 90 (54) |
Black | 42 (28) | 19 (33) | 33 (31) | 14 (22) | 37 (59) | (17) 55 | 10 (6) |
Body mass Index (kg/m2) | 30.8 ± 3.6 | 29.9 ± 2.9 | 30.6 ± 3.3 | 30.5 ± 3.3 | 30.8 ± 3.4 | 30.2 ± 3.1 | 30.6 ± 0.4 |
Minimum Waist | 96.2 ± 10.7 | 95.4 ± 9.8 | 95.7 ± 10.2 | 96.4 ± 9.6 | 96.0 ± 10.4 | 95.9 ± 9.7 | 96.9 ± 1.2 |
Circumference (cm) | |||||||
Pre-intervention peak VO2 (mL/kg/min) | 26.4 ± 6.1 | 27.9 ± 6.1 | 26.6 ± 8.8 | 27.5 ± 6.0 | 26.5 ± 6.4 | 27.7 ± 6.0 | 27.6 ± 0.7 |
p-values for two sample t-test (completers vs. non-completers) significant in STRRIDE I, STRRIDE II, and total.